Perrigo To Acquire Omega Pharma NV In $4.5 Bln Deal - Quick Facts

(RTTNews) - Drugmaker Perrigo Company plc (PRGO) has agreed to buy Omega Pharma NV for 3.6 billion euros, or $4.5 billion, comprised of the purchase of Omega's equity for 2.48 billion euros and the assumption of 1.1 billion euros in debt. Of the equity purchase price, 25% would be funded by Perrigo stock placed directly to Omega founder Marc Coucke and 75% funded via. a combination of cash and debt.

The transaction, which is funded through a combination of cash, debt, and equity, would enhance Perrigo's leading OTC product offering and expand its distribution through Omega's strong established platform.

Omega clocked nearly $1.6 billion of revenue during the year to September 30, 2014.

According to the company, the transaction accelerates international growth strategy, strengthens product portfolio while enhancing scale and distribution, financially compelling and expands International Management capabilities.